Skip to content

Aimstep Ovulation 75030

by Germaine Laboratories, Inc.

Aimstep Ovulation 75030 is a medical device (FDA Class I; FDA product code CEP, Radioimmunoassay, Luteinizing Hormone) made by Germaine Laboratories, Inc., listed in FDA GUDID since 27 Apr 2016 (UDI-DI 00695684750305), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00695684750305 UDI-DI Date27 Apr 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
A qualitative test to detect the LH surge in urine to aid in the prediction of ovulation.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Aimstep Ovulation
Generic name
Luteinizing hormone (LH) IVD, kit, rapid ICT, clinical
Model / reference
75030
Primary DI / UDI-DI
00695684750305
FDA product code
CEP
GMDN term
Luteinizing hormone (LH) IVD, kit, rapid ICT, clinical
Device class
Class I
Regulation number
862.1485
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code CEP (Radioimmunoassay, Luteinizing Hormone).

Other devices from Germaine Laboratories, Inc.

See all devices from Germaine Laboratories, Inc. →

Properties

  • Single use
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)